Research · Randomized controlled trial
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a randomized trial using a combined microcirculatory model
What it found
Both doses significantly improved microcirculation and symptom scores versus placebo (no change in placebo), with the larger effect at 120 mg/day.
- Design
- Randomized controlled trial
- Year
- 2001
- Sample size
- 99
- Population
- patients with venous hypertensive microangiopathy
- Intervention
- Centella asiatica triterpenic fraction 60 or 120 mg/day vs placebo, 8 weeks
- Outcome
- laser Doppler flowmetry, transcutaneous gas measures, symptom scores
- Journal
- Angiology
Citation last checked 2026-06-21.